Thoughtful Risk–Benefit Strategy for Global Success
We take a strategic, evidence-driven approach that balances patient safety with program success. Our team provides expert support across safety, regulatory, and evidence decisions ensuring compliance and confidence at every stage.
With global reach and multilingual capabilities, we combine specific local knowledge in the EU and US to help you navigate complex requirements. Whether it’s enrolling your Phase 2 or 3 trials, managing drug safety and pharmacovigilance, or addressing specialized operational needs, we’re here to support your success.
Core Values
The principles that guide every decision and relationship at ClinRM.
Integrity
We uphold the highest ethical standards in every interaction, ensuring trust and reliability in all our partnerships.
Transparency
Clear communication with investors and clients forms the foundation of our collaborative approach to consulting.
Patient-Centric
Every decision we make prioritizes patient safety and well-being, driving meaningful outcomes in healthcare.
What We Do
At ClinRM, we bring together clinical specialists and seasoned industry experts to deliver pharmacovigilance, medical affairs, and US/EU regulatory support tailored to your development needs. We collaborate closely with your team to solve complex challenges and ensure smooth, compliant operations from early-stage trials to market approval.
Integrated Medical Oversight
Seamless alignment between safety signaling and medical affairs to ensure robust data interpretation and communication.
Transatlantic Regulatory Precision
Expert guidance through FDA and EMA pathways, ensuring streamlined compliance from IND/CTA to post-market reporting.
Expert Network
Access to specialized physicians and consultants who understand your therapeutic area and business priorities.
Our Vision
To advance life-saving therapies through pragmatic clinical insight that protects patients and advances programs.
We partner with innovators to navigate complex safety and regulatory challenges with precision, ensuring critical treatments reach patients without compromise to scientific integrity or development timelines.
Meet Our Expert Team
Our team brings decades of combined experience in clinical research, regulatory strategy, and pharmaceutical development. We’re dedicated to delivering exceptional results for our clients.
MB
Marc Ballas
SVP, Head of Clinical Development
PH
Peter Hammerman
Chief Scientific Officer
NL
Neil Lineberry
VP, Corporate Development
NM
Nazareth Martinez
VP, Strategic Finance
MM
Michael Morrison
VP, Biochemistry & Biophysics
AP
Asit Parikh
Chief Executive Officer
AT
Adam Thomas
Chief Administrative Officer
Let's Discuss Your Project
Ready to elevate your regulatory strategy? Our team of experts is here to help you navigate complex challenges and achieve your goals.
